Niro Attys Again Face Sanctions In Sloan-Kettering IP Row
A New York federal judge ruled Wednesday that a biopharmaceutical company can refile its suit seeking to reclaim gene therapy patent rights from the Sloan-Kettering Institute in state court, but said...To view the full article, register now.
Already a subscriber? Click here to view full article